A federal judge has overturned a jury verdict that favored an Interior Department whistleblower who alleged that Kerr-McGee Corp. had underpaid royalties for oil and gas it pumped in the Gulf of Mexico.
In a ruling that clarifies the meaning of the term “original source” in cases brought under the False Claims Act, the U.S. Supreme Court held that a retired engineer who filed a qui tam suit over practices at the nuclear weapons plant where he worked is not eligible to share $4.2 million the government won after fraud at the plant came to light.
A former marketing vice president at Pfizer Inc. is appealing the dismissal of his whistleblower lawsuit accusing the pharmaceutical giant of illegally marketing a successful biotechnology drug, human growth hormone Genotropin.
A New Jersey hospital will pay $7.5 million to settle allegations that it overcharged Medicare patients in order to collect more money from the government.
Pepper Hamilton LLP has snagged a former attorney with the Department of Justice to join its white collar criminal defense and pharmaceutical and medical device litigation and counseling practices.
Before the ink could dry on the ruling, Amerigroup Corp. said it would file an appeal of a federal judge’s decision that the company and its Illinois unit should pay $190 million in civil penalties, bringing the company’s total liability to $334 million in a suit alleging it discriminated against pregnant women.
Irish pharmaceutical company Elan Corp. is facing a kickback probe from the U.S. Department of Justice and the Department of Health over the promotion of epilepsy drug Zonegran for off-label uses.
Even though the U.S. Securities and Exchange Commission and auditors have been finding more corporate fraud since the Sarbanes-Oxley Act was passed in 2002, they are still not doing enough, according to a new academic study.
A district court judge approved a $5 million settlement Monday in a class action securities suit stockholders filed against managed health care company Amerigroup Corp.
Health care providers and their attorneys are scrambling to get in compliance with new regulations mandating that companies educate employees about detecting and reporting Medicaid fraud to the government.
The U.S. Department of Justice has joined a whistleblower lawsuit against an Ohio-based drug company it is responsible for inflating claims to Medicare and Medicaid claims by as much as 1,000%.
The Small Business Administration has launched a thorough review of loans made by Business Loan Express LLC after a former senior executive was indicted on criminal charges.
Kerr-McGee Corp. suffered a huge loss in court after a jury agreed with a former Department of the Interior auditor and whistleblower who was fired after claiming that the oil company had cheated the government out of millions of dollars in royalties.
In a blow to a whistleblower who sued Medtronic Inc. on allegations that the medical device maker offered kickbacks to doctors who used the company’s spinal products, a court has tossed the action on the grounds that it is duplicative of a second whistleblower’s suit.
Though about 35% of the Texas population is Hispanic, many law firms in the state have few or no Spanish-speaking attorneys. Monty Partners LLP, a small labor and employment firm based in Houston, is uniquely different.
A federal judge has sentenced a subsidiary of Schering-Plough Corp. to pay a $180 million criminal fine for Medicaid fraud and improper marketing of drugs.
A judge has rejected an argument that a state lawsuit accusing pharmaceutical companies of publishing false average wholesale prices for their drugs as a way to bilk Medicare should be tried in federal court.
Weeks after a jury first ordered Amerigroup Corp. to pay $144 million for discriminating against pregnant women and other high-risk patients, the health insurance company has revealed it could be asked to shell out a whopping $525 million instead.
Whistleblowers helped the U.S. government recover a record $3.1 billion in fraud cases in the past fiscal year, propelled to a large extent by sharp rise in recoveries in the health care industry.
In an unusual twist, a judge overseeing a long-running legal battle between Boeing Co. and its shareholders over the aerospace giant’s procurement scandals has delayed a $12 million settlement deal in order to revisit the testimony of six plaintiffs who were represented in the case by Milberg Weiss Bershad & Schulman LLP.